Predictions
Sanofi S.A.
Start price
Target price
Perf. (%)
€79.36
11.08.22
11.08.22
€110.00
11.08.23
11.08.23
22.37%
12.08.23
12.08.23
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
Valneva SE
Start price
Target price
Perf. (%)
€10.23
09.08.22
09.08.22
€14.00
09.08.23
09.08.23
-46.91%
30.05.23
30.05.23
Small cyclical dependencies
Below average Marketposition
Few uniques
Cellectis Nom.
Start price
Target price
Perf. (%)
€3.52
07.08.22
07.08.22
€3.80
07.08.23
07.08.23
-52.13%
08.08.23
08.08.23
Could be worthwhile Investment >10% per year
Abivax S.A.
Start price
Target price
Perf. (%)
€9.10
04.08.22
04.08.22
-
04.08.23
04.08.23
81.32%
05.08.23
05.08.23
Could be very worthwhile Investment >20% year
EssilorLuxottica SA
Start price
Target price
Perf. (%)
€157.25
29.07.22
29.07.22
€200.00
29.07.23
29.07.23
14.87%
30.07.23
30.07.23
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
EssilorLuxottica SA
Start price
Target price
Perf. (%)
€154.40
23.07.22
23.07.22
€170.00
23.08.22
23.08.22
5.63%
11.08.22
11.08.22
Could be very worthwhile Investment >20% year
Innovative
Sustainability is important
Small cyclical dependencies
Valneva SE
Start price
Target price
Perf. (%)
€9.82
21.07.22
21.07.22
-
21.07.23
21.07.23
-30.16%
22.07.23
22.07.23
Revenue growth >5% per year expected
Could be very worthwhile Investment >20% year
High valuation
Growths slower than the competition
EssilorLuxottica SA
Start price
Target price
Perf. (%)
€146.15
15.07.22
15.07.22
€155.00
15.07.23
15.07.23
5.64%
23.07.22
23.07.22
Could be very worthwhile Investment >20% year
Innovative
Sustainability is important
Small cyclical dependencies
EssilorLuxottica SA
Start price
Target price
Perf. (%)
€146.15
15.07.22
15.07.22
€175.00
15.07.23
15.07.23
21.16%
16.07.23
16.07.23
Gensight Biologics SA
Start price
Target price
Perf. (%)
€2.34
07.04.22
07.04.22
-
07.04.23
07.04.23
-1.02%
08.04.23
08.04.23
Could be worthwhile Investment >10% per year
Valneva SE
Start price
Target price
Perf. (%)
€15.60
30.03.22
30.03.22
-
30.03.23
30.03.23
-55.74%
20.11.22
20.11.22
Could be worthwhile Investment >10% per year
Very valuable balance sheet
Eurobio scientific
Start price
Target price
Perf. (%)
€19.28
14.03.22
14.03.22
€21.00
14.03.23
14.03.23
-10.58%
05.10.22
05.10.22
Could be worthwhile Investment >10% per year
Gensight Biologics SA
Start price
Target price
Perf. (%)
€2.97
07.03.22
07.03.22
-
07.03.23
07.03.23
-19.53%
08.03.23
08.03.23
Risky Investment
Innate Pharma
Start price
Target price
Perf. (%)
€2.51
07.03.22
07.03.22
-
07.03.23
07.03.23
21.39%
08.03.23
08.03.23
Probably not worthwhile Investment
Poxel S.A.
Start price
Target price
Perf. (%)
€3.04
20.02.22
20.02.22
€4.00
20.03.22
20.03.22
-11.39%
21.03.22
21.03.22
Could be worthwhile Investment >10% per year
Sartorius Stedim Biotech S.A.
Start price
Target price
Perf. (%)
€328.00
20.02.22
20.02.22
€400.00
20.02.23
20.02.23
1.01%
21.02.23
21.02.23
Could be worthwhile Investment >10% per year
Orpea Nom.
Start price
Target price
Perf. (%)
€36.36
19.02.22
19.02.22
€32.00
19.02.23
19.02.23
-5.42%
05.03.22
05.03.22
Risky Investment
Poxel S.A.
Start price
Target price
Perf. (%)
€4.07
15.02.22
15.02.22
€5.00
15.03.22
15.03.22
-25.36%
20.02.22
20.02.22
Could be worthwhile Investment >10% per year
Innate Pharma
Start price
Target price
Perf. (%)
€3.24
10.02.22
10.02.22
€3.80
10.02.23
10.02.23
-4.81%
11.02.23
11.02.23
Could be worthwhile Investment >10% per year
Orpea Nom.
Start price
Target price
Perf. (%)
€34.38
06.02.22
06.02.22
€31.00
06.02.23
06.02.23
5.76%
19.02.22
19.02.22
Risky Investment
Valneva SE
Start price
Target price
Perf. (%)
€15.03
05.02.22
05.02.22
€20.00
05.02.23
05.02.23
-57.41%
06.02.23
06.02.23
Revenue growth >5% per year expected
Differentiated customer and product portfolio
Good culture
Could be very worthwhile Investment >20% year
Theranexus
Start price
Target price
Perf. (%)
€3.18
04.02.22
04.02.22
€36.00
04.02.23
04.02.23
-41.98%
05.02.23
05.02.23
Could be worthwhile Investment >10% per year